IL18 and cancer: Considering the effect of macrophage CM on the upregulation of factors to increase vascular permeability21,22, both M1 and M2 CM-treated cancer cells showed increased expression of angiopoietin-like 4 (ANGPTL-4), and M2-CM-treated cells expressed higher levels of IL-18 (Supplementary Figure 3k–l).